These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 62454)

  • 21. [Optimal temperature of enzyme activity and heat resistance of neuraminidases as attenuation markers for influenza viruses].
    Profeta ML; Ferrante P; Kotseva R
    Boll Ist Sieroter Milan; 1977 Nov; 56(5):410-7. PubMed ID: 597391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neuraminidase antigenic erythrocytic diagnostic agent in determining antibodies to the neuraminidase of influenza A viruses].
    Tamendarova NCh; Shuratov IKh; Karal'nik BV; Ansarieva KG; Nietkalieva SA
    Vopr Virusol; 1985; 30(3):369-73. PubMed ID: 2413631
    [No Abstract]   [Full Text] [Related]  

  • 23. [Genomic and antigenic analysis of strains of influenza A virus (H1N1) isolated in 1982-1983: approaches to the choice of the optimal vaccine strain].
    Akopova II; Klimov AI; Unanov SS; Krasnova VP; Grinbaum EB
    Vopr Virusol; 1986; 31(3):288-92. PubMed ID: 2429448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laboratory characterization of influenza A viruses (H3N2)--pathogens of Leningrad 1983 epidemic.
    Luzyanina TYa ; Grinbaum EB; Yukhnova LG; Klimov AI; Ghendon YuZ ; Golubev DB
    Acta Virol; 1986 Jul; 30(4):294-302. PubMed ID: 2429534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antigenic heterogeneity of influenza virus B neuraminidases].
    Molibog EV; Zakstel'skaia LIa; Iakhno MA; Shenderovich SF
    Vopr Virusol; 1982; 27(2):159-61. PubMed ID: 6178216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition.
    Johansson BE; Kilbourne ED
    Virology; 1996 Nov; 225(1):136-44. PubMed ID: 8918540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antineuraminidase serum antibodies in natural influenza A and immunization with influenza vaccines].
    Naĭkhin AN; Tsaritsyna IM; Syrodoeva LG; Oleĭnikova EV; Gorev NE
    Vopr Virusol; 1983; (2):154-9. PubMed ID: 6868553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Universal influenza vaccines: developments, prospects for use].
    Tsybalova LM; Kiselev OI
    Vopr Virusol; 2012; 57(1):9-14. PubMed ID: 22624467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Protective antigen of influenza virus].
    Nobusawa E
    Nihon Rinsho; 1997 Oct; 55(10):2719-24. PubMed ID: 9360397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of the antigenic properties of strains of influenza virus that caused the epidemic of 1974-1975].
    Zakstel'ska LIa; Shenderovich SF; Molibog EV; Iakhno MA
    Vopr Virusol; 1976; (6):702-6. PubMed ID: 67716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antigenic drift of current influenza A viruses].
    Ivanova NA; Luzianina TIa; Taros LIu; Grinbaum EB; Rumel' NB
    Vopr Virusol; 1977; (2):168-73. PubMed ID: 898892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Characteristics of neuraminidase N1 from human influenza A viruses].
    Grinbaum EB; Ivanova NA; Luzianina TIa
    Tr Inst Im Pastera; 1982; 59():20-3. PubMed ID: 6196880
    [No Abstract]   [Full Text] [Related]  

  • 33. Neuraminidase antibodies in serum and nasal washings after immunization by means of live and killed whole virion, split virion and subunit (HA and N) influenza vaccines.
    Kuwert EK; Höher PG; Werner J; Scheiermann N; Thraenhart O; Müller B; Kleber G
    Dev Biol Stand; 1977 Jun 1-3; 39():77-83. PubMed ID: 604137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antigenic-genetic connections between human and animal influenza viruses].
    Rovnova ZI; Isaeva EI; Platonova AL; Kosiakov PN
    Vopr Virusol; 1989; 34(5):553-7. PubMed ID: 2481903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
    Li S; Liu C; Klimov A; Subbarao K; Perdue ML; Mo D; Ji Y; Woods L; Hietala S; Bryant M
    J Infect Dis; 1999 May; 179(5):1132-8. PubMed ID: 10191214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antigenic characteristics of different variants of influenza virus A(H3/N2) and their circulation in the USSR and People's Republic of Bulgaria in 1968-1980].
    Zakstel'skaia LIa; Nikolova Z; Iakhno MA; Shenderovich SF; Oskerko TA
    Vopr Virusol; 1982; 27(6):671-6. PubMed ID: 6186088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influenza viral neuraminidase: the forgotten antigen.
    Johansson BE; Cox MM
    Expert Rev Vaccines; 2011 Dec; 10(12):1683-95. PubMed ID: 22085172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Variability of influenza A2 viruses in nature].
    Sokolov MI; Podcherniaeva RIa
    Vopr Virusol; 1975; (4):424-9. PubMed ID: 1216834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of envelope antigens of influenza A (H3N2) virus isolated during 1983-1985 epidemics and from sporadic cases of infection.
    Stumpa A; Tůmová B; Luther P
    J Hyg Epidemiol Microbiol Immunol; 1988; 32(2):173-80. PubMed ID: 3411119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees.
    Kilbourne ED; Cerini CP; Khan MW; Mitchell JW; Ogra PL
    J Immunol; 1987 May; 138(9):3010-3. PubMed ID: 3571981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.